Metabolic dysfunction-associated steatotic liver disease (MASLD) affects approximately 30% of adults, with about 30% of cases progressing to metabolic dysfunction-associated steatohepatitis (MASH), ...
The field of cardiovascular endocrinology has witnessed significant advancements with the arrival of incretin-based therapies, originally designed for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results